CAP Pro Course - Immunology - Molecular Amplification Methods for Detection of Infectious Diseases (2025 & 2026)

Author: Kevin Foley PhD, MLS, DABCC
Reviewers: David J. Moffa, Ph.D., BCLD and Lindsey M. Wilson, MLS(ASCP)CM

Continuing Education Credits

Objectives

  • Identify the advantages of nucleic acid amplification testing (NAAT) for detection of infectious diseases and discuss factors that could limit effectiveness.
  • Explain the difference between target amplification and signal amplification and give examples of each method.
  • Describe the principles of polymerase chain reaction (PCR) and reverse transcriptase polymerase chain reaction (RT-PCR).
  • Identify procedural processes that are necessary when using amplification methods to ensure reliable test results.

Course Outline

  • Identify the advantages of nucleic acid amplification testing (NAAT) for detection of infectious diseases and discuss factors that could limit effectiveness.
      • Key Benefits of Molecular Methods
      • Key Benefits of Molecular Methods: Improved Sensitivity of Detection
      • Key Benefits of Molecular Methods: Reduced Turnaround Time
      • Key Benefits of Molecular Methods: Ease of Performance
      • Specificity and Sensitivity of Laboratory Methods for Detection of Bordetella pertussis as an Example
      • Preanalytical Factors Affecting Nucleic Acid Amplification Testing (NAAT)
      • You receive a nasopharyngeal swab for a flu test in your rural hospital laboratory. Upon inspection of the specimen, you realize that it was collected...
      • Lucy is a technologist at a molecular reference laboratory. Today, she received a shipment of patient specimens collected in EDTA tubes to be tested b...
      • What is one disadvantage to using nucleic acid amplification testing (NAAT) for the detection of B. pertussis?
      • You are instructing a patient on how to collect an unpreserved urine specimen for Chlamydia nucleic acid amplification testing (NAAT). Which of the fo...
      • You are describing the advantages of PCR over viral culture for the detection of influenza. Which choice represents the best explanation?
  • Explain the difference between target amplification and signal amplification and give examples of each method.
      • Categories of Molecular Assays
      • Polymerase Chain Reaction (PCR)
      • Other Target Amplification Methods
      • Examples of Signal Amplification Methods
      • Newer Assays
      • Multiplexing
      • From the listed target amplification methods, which one can be utilized to detect either target DNA or target RNA?
      • If N represents the number of cycles in a PCR program, which formula determines the approximate number of amplicons present once all the cycles of the...
      • Of the following molecular methods, which one is more susceptible to residual DNA contaminating a work surface?
      • Which of the following assays requires thermocycling at multiple temperatures?
      • What kind of amplification occurs in a reverse transcriptase chain reaction?
      • Which type of nucleic acid molecular methodology mimicks the in vivo process of DNA replication?
  • Describe the principles of polymerase chain reaction (PCR) and reverse transcriptase polymerase chain reaction (RT-PCR).
      • Polymerase Chain Reaction (PCR)
      • Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
      • Detection of PCR Products
      • Microarrays
      • Real-Time PCR
      • Melt Curve Analysis
      • What is the method in which amplification and detection occur simultaneously within the same reaction tube, contributing to a shortened turnaround tim...
      • Reverse transcriptase PCR (RT-PCR) is used for the detection of viruses that have an RNA genome. Which of the following is not an RNA virus?
      • In which of the following PCR steps is the reaction mixture cooled to a temperature between 50° and 70°C?
      • When using melt curve analysis, all PCR products for a specific primer pair should have the same melting temperature unless which of the following occ...
  • Identify procedural processes that are necessary when using amplification methods to ensure reliable test results.
      • Concerns for Cross-Contamination
      • Designated Work Areas and Processes
      • Required Work Skills and Process Controls
      • A new medical laboratory science student is being trained in the molecular laboratory. Her trainer is going over potential cross-contamination causes ...
      • While preparing her materials for tonight's shift in the molecular laboratory, Jen spilled a tube of positive control in the reagent preparation area....
      • You are evaluating results from a PCR assay. The positive and negative controls are acceptable; there are 10 negative samples and three positive sampl...
      • How could the presence of hemoglobin in a sample affect a nucleic acid amplification test (NAAT)?
      • If a reagent blank yields a positive result, which of the following would not be an appropriate action?
      • You are working in a molecular laboratory and are tasked with preparing reagents. Which of the following pipettes is recommended for such a task?
      • While preparing to run today's batch of automated NAAT HIV testing, you are training a new technologist. In which order should you tell the new techno...
  • References
      • References

Additional Information

Level of Instruction: Intermediate
Intended Audience: This program is designed as an educational and training tool for MLS, MT, and MLT personnel, medical laboratory science students and interns, pathology residents, and practicing pathologists.
Author Information: Kevin F. Foley, PhD, DABCC, MLS, SC is the director of clinical pathology for the Kaiser Permanente Northwest region. He also teaches clinical chemistry at Oregon Health Sciences University. Dr. Foley earned his PhD in clinical pharmacology and toxicology at East Carolina School of Medicine in North Carolina. He recieved a PhD in clinical pharmacology and toxicology from Brody School of Medicine, Greenville, NC. He has been working in laboratory medicine for over 15 years, starting his career as a medical technologist.
Reviewer Information:
David J. Moffa, PhD, BCLD, has over 30 years of experience in the healthcare industry as an executive manager, clinical laboratory director, and medical laboratory scientist. He is currently a technical consultant for Kentmere Healthcare, Wilmington, DE, and until his retirement, was the Regional Director for LabCorp, Inc. He holds a PhD in medical biochemistry from the School of Medicine at West Virginia University.
Lindsey M. Wilson, MLS(ASCP)CM, received her Bachelor of Science in Biology from Utah State University in Logan, UT. After working in her local hospital laboratory, she fell in love with the Medical Laboratory Science field and went on to receive her Associate of Science in Medical Laboratory Science from Weber State University in Ogden, UT. She worked as a medical laboratory scientist in the hospital laboratory for four years before transitioning to her current role as Laboratory Technical Consultant for Intermountain Health. Her areas of expertise include microbiology, hematology, and point-of-care testing.

This course is part of the CAP Competency Assessment Hub.

See other included Pro courses

See other included instrument checklists